|
Re: Lu stepping down
|
5
|
Resverlogix Corp.
|
Feb 21, 2024 07:19PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
5
|
Resverlogix Corp.
|
Mar 23, 2020 06:11PM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
5
|
Resverlogix Corp.
|
Sep 15, 2018 01:03PM
|
|
Replace "Stroke Mace" with "CHF Mace"
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 09:11AM
|
|
Re: RVXCF New 52 week high, $3.59 USD....
|
5
|
Resverlogix Corp.
|
Apr 23, 2019 10:33AM
|
|
Re: Another Exempt Distribution -2022-06-02
|
5
|
Resverlogix Corp.
|
Jun 06, 2022 08:46AM
|
|
Re: More Exempt Distribution Investments
|
5
|
Zenith Epigenetics
|
Jan 05, 2024 05:24PM
|
|
Exempt Distribution- 2021-04-12
|
5
|
Resverlogix Corp.
|
Apr 14, 2021 11:18AM
|
|
Re: Why is "Going it Alone" out of the question??
|
5
|
Resverlogix Corp.
|
Aug 14, 2020 11:50AM
|
|
Re: BETonMACE Placebo Estimate
|
5
|
Resverlogix Corp.
|
Feb 20, 2019 09:30AM
|
|
FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
5
|
Resverlogix Corp.
|
Apr 05, 2022 10:37AM
|
|
Re: Why is "Going it Alone" out of the question??
|
5
|
Resverlogix Corp.
|
Aug 14, 2020 12:44PM
|
|
Re: Reports of Exempt Distribution
|
5
|
Zenith Epigenetics
|
Feb 09, 2023 08:01AM
|
|
Re: Comments on today's annual update
|
5
|
Resverlogix Corp.
|
Jun 23, 2021 06:34AM
|
|
Re: Voting reminder
|
5
|
Resverlogix Corp.
|
Jun 11, 2023 10:09AM
|
|
Re: Interesting.
|
5
|
Resverlogix Corp.
|
Nov 24, 2021 11:44AM
|
|
Re: Summary of ongoing and planned clinical trials
|
5
|
Zenith Epigenetics
|
Dec 23, 2020 08:49PM
|
|
Re: R & D
|
5
|
Resverlogix Corp.
|
Jul 30, 2019 12:34PM
|
|
Re: Is this bad for RVX but right, on the money?
|
5
|
Resverlogix Corp.
|
Apr 19, 2020 09:14PM
|
|
Re: Interesting Trades / Volume .....
|
5
|
Resverlogix Corp.
|
Jan 26, 2019 05:10AM
|
